Search for Clinical Trial Results

Sponsored By

Multifocal Motor Neuropathy - 10 Studies Found

Status Study
Completed Study Name: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
Condition: Multifocal Motor Neuropathy
Date: 2013-04-01
Interventions: Drug: NPB-01 Other Name: immunoglobulin
Completed Study Name: Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Date: 2005-12-21
Interventions:
  • Drug: Subcutaneous immunoglobulin

Not yet recruiting Study Name: HyQvia in Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Date: 2016-01-25
Interventions: Drug: rHuPH20 human immunoglobulin and one vial of recombinant human hyaluronidase
Completed Study Name: Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Date: 2008-04-23
Interventions:
  • Biological: Immune Globulin Intravenous (human), 10%

Enrolling by invitation Study Name: Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy
Date: 2015-09-18
Interventions:
  • Drug: HyQvia Human immunoglobu
Completed Study Name: A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy (MMN)
Date: 2008-06-18
Interventions: Biological: Vivaglobin Other Name: Human Normal Immunoglobulin
Completed Study Name: Effect of Resistance and Aerobic Exercise in CIDP or MMN
Condition:
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Multifocal Motor Neu
    Date: 2014-02-17
    Interventions:
    • Other: Resistance training

Completed Study Name: LIME Study (LFB IVIg MMN Efficacy Study)
Condition: Motor Neuron Disease
Date: 2013-09-20
Interventions:
  • Drug: Biological : I10E (Human normal Immunoglobulin for intravenous adminis
Completed Study Name: Immunoglobulin Dosage and Administration Form in CIDP and MMN
Condition:
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Multifocal Motor Neu
    Date: 2014-04-09
    Interventions: Drug: Immunoglobulins SCIG dosage is individualized for each patient according to previous IVIG dosage
Completed Study Name: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Condition:
  • Guillain-Barre Syndrome
  • CIDP
  • Multifo
    Date: 2012-07-30